0001104659-23-072607.txt : 20230620 0001104659-23-072607.hdr.sgml : 20230620 20230620081654 ACCESSION NUMBER: 0001104659-23-072607 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230616 FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oliviero James F III CENTRAL INDEX KEY: 0001434718 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41264 FILM NUMBER: 231023465 MAIL ADDRESS: STREET 1: C/O KERYX BIOPHARMACEUTICALS, INC. STREET 2: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvectis Pharma, Inc. CENTRAL INDEX KEY: 0001875558 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862405608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 BUSINESS PHONE: 360-837-7232 MAIL ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 4 1 tm2319007-3_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-16 0 0001875558 Nuvectis Pharma, Inc. NVCT 0001434718 Oliviero James F III C/O NUVECTIS PHARMA, INC., 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 1 0 0 0 0 Common Stock 2023-06-16 4 A 0 18000 0 A 27828 D The 18,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Oliviero's continued service on the board on such dates. /s/ James F. Oliviero III 2023-06-20